Viewing StudyNCT00192478



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00192478
Status: COMPLETED
Last Update Posted: 2008-07-28
First Post: 2005-09-13

Brief Title: Open-Label Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mgkg or 15 mgkg Children to be Followed for 90 Days After Their Last Dose of MEDI-524
Sponsor:
Organization: MedImmune LLC

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 217
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: